{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:21:58Z","timestamp":1768440118485,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,16]],"date-time":"2012-07-16T00:00:00Z","timestamp":1342396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1752-1947-6-201","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T15:20:17Z","timestamp":1342538417000},"source":"Crossref","is-referenced-by-count":8,"title":["Mantle cell lymphoma of the larynx: Primary case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Sarah","family":"Naciri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anass A","family":"Bennani-Baiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Glaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Mouzount","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Essakali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Kzadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,16]]},"reference":[{"issue":"2","key":"2136_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0344-0338(11)80562-5","volume":"191","author":"HP Horny","year":"1995","unstructured":"Horny HP, Kaiserling E: Involvement of the larynx by hemopoietic neoplasms. An investigation of autopsy cases and review of the literature. Pathol Res Pract. 1995, 191 (2): 130-138. 10.1016\/S0344-0338(11)80562-5.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"2136_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/000348949610500716","volume":"105","author":"HP Horny","year":"1996","unstructured":"Horny HP, Ferlito A, Carbone A: Laryngeal lymphoma derived from mucosa-associated lymphoid tissue. Ann Otol Rhinol Laryngol. 1996, 105 (7): 577-583.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"2136_CR3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","volume":"14","author":"GA Velders","year":"1996","unstructured":"Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Schuuring E, Kramer MH, van Deijk WA, Rahder JB, Kluin PM, van Krieken JH: Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol. 1996, 14 (4): 1269-1274.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2136_CR4","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood. 1997, 89 (11): 3909-3918.","journal-title":"Blood"},{"issue":"2","key":"2136_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/014556130608500216","volume":"85","author":"R Word","year":"2006","unstructured":"Word R, Urquhart AC, Ejercito VS: Primary laryngeal lymphoma: case report. Ear Nose Throat J. 2006, 85 (2): 109-111.","journal-title":"Ear Nose Throat J"},{"issue":"4","key":"2136_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hed.21104","volume":"32","author":"K Markou","year":"2010","unstructured":"Markou K, Goudakos J, Constantinidis J, Kostopoulos I, Vital V, Nikolaou A: Primary laryngeal lymphoma: report of 3 cases and review of the literature. Head Neck. 2010, 32 (4): 541-549.","journal-title":"Head Neck"},{"issue":"7","key":"2136_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3174\/ajnr.A2085","volume":"31","author":"NA Siddiqui","year":"2010","unstructured":"Siddiqui NA, Branstetter BF, Hamilton BE, Ginsberg LE, Glastonbury CM, Harnsberger HR, Barnes EL, Myers EN: Imaging characteristics of primary laryngeal lymphoma. AJNR Am J Neuroradiol. 2010, 31 (7): 1261-1265. 10.3174\/ajnr.A2085.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"2136_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0194-5998(99)70079-3","volume":"121","author":"CJ Cheng","year":"1999","unstructured":"Cheng CJ, Chen PR, Liu MC, Kuo MS, Hsu YH: Primary malignant lymphoma of mucosa-associated lymphoid tissue of larynx. Otolaryngol Head Neck Surg. 1999, 121 (5): 661-662. 10.1016\/S0194-5998(99)70079-3.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"2136_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/adpa.2002.30611","volume":"6","author":"EK Fung","year":"2002","unstructured":"Fung EK, Neuhauser TS, Thompson LD: Hodgkin-like transformation of a marginal zone B-cell lymphoma of the larynx. Ann Diagn Pathol. 2002, 6 (1): 61-66. 10.1053\/adpa.2002.30611.","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"2136_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.critrevonc.2005.10.001","volume":"58","author":"J Brody","year":"2006","unstructured":"Brody J, Advani R: Treatment of mantle cell lymphoma: current approach and future directions. Crit Rev Oncol Hematol. 2006, 58 (3): 257-265. 10.1016\/j.critrevonc.2005.10.001.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 4","key":"2136_CR11","doi-asserted-by":"crossref","first-page":"iv41","DOI":"10.1093\/annonc\/mdn193","volume":"19","author":"M Dreyling","year":"2008","unstructured":"Dreyling M, Weigert O, Hiddemann W: Current treatment standards and future strategies in mantle cell lymphoma. Ann Oncol. 2008, 19 (Suppl 4): iv41-iv44.","journal-title":"Ann Oncol"},{"issue":"4","key":"2136_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/JCO.2005.04.164","volume":"23","author":"M Ghielmini","year":"2005","unstructured":"Ghielmini M, Schmitz SF, Cogliatti S, Bertoni F, Waltzer U, Fey MF, Betticher DC, Schefer H, Pichert G, Stahel R, Ketterer N, Bargetzi M, Cerny T, Swiss Group for Clinical Cancer Research: Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J Clin Oncol. 2005, 23 (4): 705-711. 10.1200\/JCO.2005.04.164.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2136_CR13","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","volume":"23","author":"G Lenz","year":"2005","unstructured":"Lenz G, Dreyling M, Hoster E, W\u00f6rmann B, D\u00fchrsen U, Metzner B, Eimermacher H, Neubauer A, Wandt H, Steinhauer H, Martin S, Heidemann E, Aldaoud A, Parwaresch R, Hasford J, Unterhalt M, Hiddemann W: Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol. 2005, 23 (9): 1984-1992. 10.1200\/JCO.2005.08.133.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2136_CR14","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1200\/JCO.20.5.1288","volume":"20","author":"OM Howard","year":"2002","unstructured":"Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ, Shipp MA: Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol. 2002, 20 (5): 1288-1294. 10.1200\/JCO.20.5.1288.","journal-title":"J Clin Oncol"},{"issue":"1 Suppl 2","key":"2136_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/sonc.2002.30143","volume":"29","author":"J Mangel","year":"2002","unstructured":"Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL: Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. Semin Oncol. 2002, 29 (1 Suppl 2): 56-69.","journal-title":"Semin Oncol"},{"issue":"11","key":"2136_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/annonc\/mdh425","volume":"15","author":"W Brugger","year":"2004","unstructured":"Brugger W, Hirsch J, Grunebach F, Repp R, Brossart P, Vogel W, Kopp HG, Manz MG, Bitzer M, Schlimok G, Kaufmann M, Ganser A, Fehnle K, Gramatzki M, Kanz L: Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Ann Oncol. 2004, 15 (11): 1691-1698. 10.1093\/annonc\/mdh425.","journal-title":"Ann Oncol"},{"issue":"3","key":"2136_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/sj.bmt.1702135","volume":"25","author":"D Decaudin","year":"2000","unstructured":"Decaudin D, Brousse N, Brice P, Haioun C, Bourhis JH, Morel P, Van Hoof A, Souleau B, Quesnel B, Gisselbrecht C: Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study. Bone Marrow Transplant. 2000, 25 (3): 251-256. 10.1038\/sj.bmt.1702135.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2136_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/annonc\/mdn656","volume":"20","author":"A Goy","year":"2009","unstructured":"Goy A, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Nasta S, O'Connor OA, Shi H, Boral AL, Fisher RI: Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Ann Oncol. 2009, 20 (3): 520-525.","journal-title":"Ann Oncol"},{"issue":"8","key":"2136_CR19","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2004-03-1091","volume":"104","author":"H Kaufmann","year":"2004","unstructured":"Kaufmann H, Raderer M, Wohrer S, P\u00fcsp\u00f6k A, Bankier A, Zielinski C, Chott A, Drach J: Antitumor activity of rituximab plus thalidomide in patients with relapsed\/refractory mantle cell lymphoma. Blood. 2004, 104 (8): 2269-2271. 10.1182\/blood-2004-03-1091.","journal-title":"Blood"},{"issue":"9","key":"2136_CR20","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1200\/jco.2003.09.057","volume":"21","author":"CT Kouroukis","year":"2003","unstructured":"Kouroukis CT, Belch A, Crump M, Gascoyne RD, Chua NS, Buckstein R, Turner R, Assouline S, Klasa RJ, Walsh W, Powers J, Eisenhauer E: Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2003, 21 (9): 1740-1745. 10.1200\/jco.2003.09.057.","journal-title":"J Clin Oncol"},{"issue":"23","key":"2136_CR21","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1200\/JCO.2005.13.466","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE, Geyer SM, Ghobrial I, Inwards DJ, Fonseca R, Kurtin P, Ansell SM, Luyun R, Flynn PJ, Morton RF, Dakhil SR, Gross H, Kaufmann SH: Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol. 2005, 23 (23): 5347-5356. 10.1200\/JCO.2005.13.466.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-6-201\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T01:03:07Z","timestamp":1714179787000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-6-201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,16]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2136"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-6-201","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,16]]},"article-number":"201"}}